Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
TPST on Nasdaq
Shares outstanding
13,473,733
Price per share
$2.81
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
517,764
Total reported value
$1,485,974
% of total 13F portfolios
0%
Share change
+201,712
Value change
+$539,434
Number of holders
19
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Angel Matthew 36% $13,205,201 4,837,070 Matthew Angel 03 Feb 2026
SABBY MANAGEMENT, LLC 9.9% $1,397,913 492,223 SABBY MANAGEMENT, LLC 31 Dec 2025

As of 31 Dec 2025, 19 institutional investors reported holding 517,764 shares of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST). This represents 3.8% of the company’s total 13,473,733 outstanding shares.

Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 517,764 $1,485,974 +$539,434 $2.87 19
2025 Q3 316,052 $3,248,899 -$2,235,429 $10.28 16
2025 Q2 674,784 $4,588,483 +$1,995,038 $6.80 17
2025 Q1 3,507,822 $2,588,773 +$2,588,773 $0.74 2